435 related articles for article (PubMed ID: 22596253)
1. Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?
Griebel G; Holsboer F
Nat Rev Drug Discov; 2012 May; 11(6):462-78. PubMed ID: 22596253
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Receptor Ligands for the Treatment of Schizophrenia: Focus on Neurotensin and Tachykinins.
Griebel G
Curr Pharm Des; 2015; 21(26):3807-12. PubMed ID: 26044977
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety.
Keck ME
Amino Acids; 2006 Oct; 31(3):241-50. PubMed ID: 16733617
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide systems and schizophrenia.
LaCrosse AL; Olive MF
CNS Neurol Disord Drug Targets; 2013 Aug; 12(5):619-32. PubMed ID: 23574175
[TBL] [Abstract][Full Text] [Related]
5. The potential role of a corticotropin-releasing factor receptor-1 antagonist in psychiatric disorders.
Stahl SM; Wise DD
CNS Spectr; 2008 Jun; 13(6):467-83. PubMed ID: 18567971
[No Abstract] [Full Text] [Related]
6. Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin.
Wigger A; Sánchez MM; Mathys KC; Ebner K; Frank E; Liu D; Kresse A; Neumann ID; Holsboer F; Plotsky PM; Landgraf R
Neuropsychopharmacology; 2004 Jan; 29(1):1-14. PubMed ID: 12942143
[TBL] [Abstract][Full Text] [Related]
7. Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders?
Griebel G
Pharmacol Ther; 1999 Apr; 82(1):1-61. PubMed ID: 10341356
[TBL] [Abstract][Full Text] [Related]
8. Tachykinins and tachykinin receptors in bone.
Goto T; Tanaka T
Microsc Res Tech; 2002 Jul; 58(2):91-7. PubMed ID: 12203708
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders.
Holmes A; Heilig M; Rupniak NM; Steckler T; Griebel G
Trends Pharmacol Sci; 2003 Nov; 24(11):580-8. PubMed ID: 14607081
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach.
Hoyer D; Bartfai T
Chem Biodivers; 2012 Nov; 9(11):2367-87. PubMed ID: 23161624
[TBL] [Abstract][Full Text] [Related]
11. The role of peptides in treatment of psychiatric disorders.
Holsboer F
J Neural Transm Suppl; 2003; (64):17-34. PubMed ID: 12830927
[TBL] [Abstract][Full Text] [Related]
12. Role of corticotropin-releasing factor family peptides and receptors in stress-related psychiatric disorders.
Clark MS; Kaiyala KJ
Semin Clin Neuropsychiatry; 2003 Apr; 8(2):119-36. PubMed ID: 12728411
[TBL] [Abstract][Full Text] [Related]
13. The mammalian tachykinin ligand-receptor system: an emerging target for central neurological disorders.
Pantaleo N; Chadwick W; Park SS; Wang L; Zhou Y; Martin B; Maudsley S
CNS Neurol Disord Drug Targets; 2010 Nov; 9(5):627-35. PubMed ID: 20632965
[TBL] [Abstract][Full Text] [Related]
14. Immune challenge-stimulated hypophysiotropic corticotropin-releasing hormone messenger RNA expression is associated with an induction of neurotensin messenger RNAs without alteration of vasopressin messenger RNAs.
Juaneda C; Lafon-Dubourg P; Ciofi P; Sarrieau A; Corio M; Tramu G
Neuroscience; 1999; 93(1):393-400. PubMed ID: 10430502
[TBL] [Abstract][Full Text] [Related]
15. [Neuropeptide receptors: novel therapeutic targets for depression].
Chaki S; Okuyama S
Nihon Yakurigaku Zasshi; 2006 Mar; 127(3):196-200. PubMed ID: 16651802
[No Abstract] [Full Text] [Related]
16. Involvement of neuropeptide systems in schizophrenia: human studies.
Cáceda R; Kinkead B; Nemeroff CB
Int Rev Neurobiol; 2007; 78():327-76. PubMed ID: 17349866
[TBL] [Abstract][Full Text] [Related]
17. Neurotensin: role in psychiatric and neurological diseases.
Cáceda R; Kinkead B; Nemeroff CB
Peptides; 2006 Oct; 27(10):2385-404. PubMed ID: 16891042
[TBL] [Abstract][Full Text] [Related]
18. Tachykinin peptides, receptors, and peptidases in airway disease.
Piedimonte G
Exp Lung Res; 1995; 21(6):809-34. PubMed ID: 8591788
[No Abstract] [Full Text] [Related]
19. Identified motoneurons involved in sexual and eliminative functions in the rat are powerfully excited by vasopressin and tachykinins.
Ogier R; Tribollet E; Suarez P; Raggenbass M
J Neurosci; 2006 Oct; 26(42):10717-26. PubMed ID: 17050711
[TBL] [Abstract][Full Text] [Related]
20. Bioactive analogs of neurotensin: focus on CNS effects.
Boules M; Fredrickson P; Richelson E
Peptides; 2006 Oct; 27(10):2523-33. PubMed ID: 16882457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
